Research Today for A Better Tomorrow
Who we are
Cano Research is the clinical research arm of Cano Health that focuses on providing new and innovative treatments and diagnostic tests for our patients. We also provide opportunities for our patients to participate in academic and outcomes-based research in our network.
Why Cano Research
The patient population at Cano Health is largely diverse and allows Cano Research to attract studies that are tailored to the most common diseases in our patient population.
Phase II
Phase II trials involve more participants than Phase I trials and are designed to test both the safety and effectiveness of new treatments. These trials are instrumental to the development of cutting-edge treatments and form a part of the clinical studies portfolio of Cano Research.
Phase III
Phase III studies are the final step before seeking regulatory approval for a new treatment from organizations like the Food & Drug Administration (FDA). These trials include large populations of patients and can last multiple years. During Phase III trials, scientists, also called investigators both identify any side effects that were not observed during the Phase II trial, as well as examine the efficacy of the investigational treatment against the current standard of care.
Phase IV
Phase IV clinical trials are long-term safety and efficacy trials that occurs after the investigational treatment has been approved by the FDA.
Clinical Trials
We conduct phase II-IV trials for five vital diseases:
Clinical subjects at Cano Research have access to a wide array of clinical trials. Cano Health physicians serve as investigators for both Phase II and Phase III clinical trials for the following disease states:
- Cardiovascular Disease
- Alzheimer’s and Dimentia
- Diabetes Mellitus
- Lung Cancer
- Obesity
Cardiovascular Disease
Alzheimer’s and Dementia
Diabetes Mellitus
Lung Cancer
Obesity
Let’s work together
If you’re interested in working with us, fill the form out and we will get in contact with your company. Please make sure to leave the name, number, and email of the person we can contact regarding this information.
Contact Cano Research for More Information and Upcoming Trials